A Study to Evaluate Any Relationship between Glycosylated HaemoglobinAuthor(s): Dr. Numar Debiat
This retrospective chart review will evaluate if there are any correlations between elevated HbA1c, using the 7% ruling (recommended by the American Diabetes Association) and peripheral neuropathy found during diabetic foot assessments. Diabetes is a global endemic with rapidly increasing prevalence in both developing and developed countries. The American Diabetes Association has recommended gyrated haemoglobin (HbA1c) as a possible substitute to fasting blood glucose for diagnosis of diabetes. HbA1c is an important indicator of long-term glycaemic control with the ability to reflect the cumulative glycaemic history of the preceding two to three months. HbA1c not only provides a reliable measure of chronic hyperglycaemia but also correlates well with the risk of long-term diabetes complications. Elevated HbA1c has also been regarded as an independent risk factor for coronary heart disease and stroke in subjects with or without diabetes. The valuable information provided by a single HbA1c test has rendered it as a reliable biomarker for the diagnosis and prognosis of diabetes. This review highlights the role of HbA1c in diagnosis and prognosis of diabetes patients.